Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Income Statement 2017–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 50,000 | 14,000 | 155,000 | 374,000 | 181,000 | 11,000 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — | — | — |
| Profitability | ||||||||
| Operating Income | -47.4M | -42.6M | -29.7M | -26.0M | -29.2M | -12.2M | -12.4M | -981,480 |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Income | -45.9M | -42.1M | -30.0M | -27.3M | -30.3M | -12.1M | -12.4M | -831,486 |
| Per Share Data | ||||||||
| EPS (diluted) | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 | — | — | — |
| Shares Outstanding (dil.) | 25M | 20M | 18M | 18M | 16M | 13M | 9M | 8M |
Inmune Bio Inc. Income Statement — FAQ
Inmune Bio Inc. (INMB) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INMB's income statement history?
The chart and table above show Inmune Bio Inc.'s income statement by year and by quarter, including the growth rate.